bioAffinity Technologies, Inc. (NASDAQ:BIAFW) Short Interest Update

bioAffinity Technologies, Inc. (NASDAQ:BIAFW) was the recipient of a significant growth in short interest during the month of August. As of August 14th, there was short interest totaling 4,070 shares, a growth of 415.8% from the July 30th total of 789 shares. Based on an average daily volume of 711 shares, the days-to-cover ratio is presently 5.7 days.

bioAffinity Technologies Stock Up 42.5%

BIAFW traded up $0.03 during midday trading on Thursday, hitting $0.11. The company’s stock had a trading volume of 30 shares, compared to its average volume of 2,369. bioAffinity Technologies has a 52-week low of $0.05 and a 52-week high of $0.81. The firm has a 50-day moving average price of $0.11 and a two-hundred day moving average price of $0.21.

bioAffinity Technologies Company Profile

bioAffinity Technologies, Inc is a clinical-stage medical device company developing an extracorporeal immunoadsorption platform intended to treat Gram-negative sepsis and other severe inflammatory conditions. The company’s technology employs specialized sorbent cartridges designed to selectively bind and remove circulating endotoxins and inflammatory mediators from the bloodstream, with the goal of supporting critical care interventions and improving patient outcomes.

In preclinical studies, bioAffinity’s hemoperfusion devices have demonstrated the ability to capture lipopolysaccharides released by Gram-negative bacteria, leading to reductions in pro-inflammatory cytokines and enhanced survival rates in animal models.